Literature DB >> 8086935

Fatty acids for treating pancreatic cancer.

S J Wigmore, J S Falconer, K C Fearon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8086935      PMCID： PMC2542761          DOI： 10.1136/bmj.309.6953.544

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  Metabolism of eicosapentaenoic acid by aorta: formation of a novel 13-hydroxylated prostaglandin.

Authors:  W S Powell; F Gravelle
Journal:  Biochim Biophys Acta       Date:  1985-07-09

2.  Anticachectic and antitumor effect of eicosapentaenoic acid and its effect on protein turnover.

Authors:  S A Beck; K L Smith; M J Tisdale
Journal:  Cancer Res       Date:  1991-11-15       Impact factor: 12.701

3.  Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer.

Authors:  J S Falconer; K C Fearon; C E Plester; J A Ross; D C Carter
Journal:  Ann Surg       Date:  1994-04       Impact factor: 12.969

4.  Effect of eicosapentaenoic acid and other fatty acids on the growth in vitro of human pancreatic cancer cell lines.

Authors:  J S Falconer; J A Ross; K C Fearon; R A Hawkins; M G O'Riordain; D C Carter
Journal:  Br J Cancer       Date:  1994-05       Impact factor: 7.640
  4 in total
  2 in total

1.  Modulation of human hepatocyte acute phase protein production in vitro by n-3 and n-6 polyunsaturated fatty acids.

Authors:  S J Wigmore; K C Fearon; J A Ross
Journal:  Ann Surg       Date:  1997-01       Impact factor: 12.969

2.  Dietary supplementation with n-3-fatty acids in patients with pancreatic cancer and cachexia: marine phospholipids versus fish oil - a randomized controlled double-blind trial.

Authors:  Kristin Werner; Daniela Küllenberg de Gaudry; Lenka A Taylor; Tobias Keck; Clemens Unger; Ulrich T Hopt; Ulrich Massing
Journal:  Lipids Health Dis       Date:  2017-06-02       Impact factor: 3.876
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.